These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 5936067)
1. The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy. Sanders S Practitioner; 1966 Jun; 196(176):811-5. PubMed ID: 5936067 [No Abstract] [Full Text] [Related]
2. [Multicenter controlled trial of desensitization treatment of pollen-induced hay fever and asthma with pollinex vaccine]. Adamek-Guzik T; Szczeklik A; Wołoszyński J Pol Tyg Lek; 1979 Jul; 34(28):1111-3. PubMed ID: 390511 [No Abstract] [Full Text] [Related]
3. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. Walker SM; Pajno GB; Lima MT; Wilson DR; Durham SR J Allergy Clin Immunol; 2001 Jan; 107(1):87-93. PubMed ID: 11149996 [TBL] [Abstract][Full Text] [Related]
4. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326 [TBL] [Abstract][Full Text] [Related]
5. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. Roberts G; Hurley C; Turcanu V; Lack G J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125 [TBL] [Abstract][Full Text] [Related]
6. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma. Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U; Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798 [TBL] [Abstract][Full Text] [Related]
8. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children. Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246 [TBL] [Abstract][Full Text] [Related]
10. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978]. Wüthrich B; Häfner G Schweiz Med Wochenschr; 1980 Feb; 110(8):281-90. PubMed ID: 7367848 [TBL] [Abstract][Full Text] [Related]
11. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis. Williams A; Henzgen M; Rajakulasingam K Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386 [TBL] [Abstract][Full Text] [Related]
13. [Peroral desensitization of inhalation allergies in childhood: treatment results]. Laetsch C; Wüthrich B Schweiz Med Wochenschr; 1973 Mar; 103(9):342-7. PubMed ID: 4144381 [No Abstract] [Full Text] [Related]
14. [A new desensitization agent in the treatment of ragweed-induced seasonal allergic rhinitis (hay fever) in children: MRTA (modified ragweed tyrosine adsorbate)]. Weisnagel J Union Med Can; 1979 Jun; 108(6):685-90. PubMed ID: 116408 [No Abstract] [Full Text] [Related]
15. Ragweed immunotherapy in adult asthma. Klein JS N Engl J Med; 1996 Jul; 335(3):204; author reply 205-6. PubMed ID: 8657224 [No Abstract] [Full Text] [Related]
16. Ragweed immunotherapy in adult asthma. Weiner J; Abramson M; Pury R; Wilson J N Engl J Med; 1996 Jul; 335(3):203; author reply 205. PubMed ID: 8657222 [No Abstract] [Full Text] [Related]
17. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937 [TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and specific desensitizing treatment of allergic asthma]. Bonifazi F; Sanguinetti CM; Vennarucci LS Minerva Med; 1980 Jan; 71(3):171-6. PubMed ID: 7354934 [No Abstract] [Full Text] [Related]
20. Immunotherapy in children: past, present, and future. (Part I). Johnstone DE Ann Allergy; 1981 Jan; 46(1):1-7. PubMed ID: 6161571 [No Abstract] [Full Text] [Related] [Next] [New Search]